Treatment of kidney failure in idiopathic rhabdomyolysis with cortisone, cyclophosphamide and vincristine
Bleichner, F.; Meuret, G.
Deutsche Medizinische Wochenschrift 105(13): 451-452
1980
ISSN/ISBN: 0012-0472 PMID: 7363798 Document Number: 159475
Document emailed within 1 workday
Related Documents
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958
Sirvent, A.E.; Cabezuelo, J.B.; Enríquez, R.; Amorós, F.; González, C.; Reyes, A. 2001: Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 21(5): 497-500
Middleton, J.; Franks, D.; Buchanan, R.B.; Hall, V.; Smallwood, J.; Williams, C.J. 1985: Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine Cancer Treatment Reports 69(4): 373-375
Huang, H.; Lian, L.; Huang, R. 1995: Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide Zhonghua Fu Chan Ke Za Zhi 30(5): 265-269
Daoudal, P.; Noirot, A.; Delacour, J.L.; Floriot, C.; Wagschal, G. 1990: Rhabdomyolysis, pneumococcus infection and kidney failure Presse Medicale 19(5): 219-220
Hansen, M.M.; Bloomfield, C.D.; Jørgensen, J.; Ersbøll, J.; Pedersen-Bjergaard, J.; Blom, J.; Nissen, N.I. 1980: VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas Cancer Treatment Reports 64(10-11): 1135-1137
Timokhov, V.S.; Ipat'eva, E.I.; Iakovleva, I.I.; Romanenko, A.M.; Litvinova, N.N.; Kazakov, I.V.; Stepanova, I.E.; Kurmanova, L.V.; Merkulova, M.E.; Eremin, G.A. 1997: Plasma myoglobin and continuous hemofiltration in patients with rhabdomyolysis and acute kidney failure Terapevticheskii Arkhiv 69(6): 40-44
Pistor, K.; Graben, N.; Heber, F.; Kreuzfelder, E.; Bartholomé, K. 1984: Nontraumatic rhabdomyolysis with reversible acute kidney failure following hyperosmolar diabetic coma in a child Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 132(1): 51-54
Brun, B.; Kuentz, M.; Man, N.G.; Feuilhade, F.; Bierling, P.; Vernant, J.P.; Farcet, J.P.; Cordonnier, C.; Reyes, F.; Dreyfus, B.; Rochant, H. 1983: Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases Presse Medicale 12(19): 1205-1210
Bilgi, O.; Karagoz, B.; Alacacioglu, A.; Ozgun, A.; Tuncel, T.; Gokhan-Kandemir, E. 2010: Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second-line treatment after platinum and etoposide in small-cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 15(2): 395
Genova, R.; Marchi, A.; Zaverio, S. 1977: Our experiences in the treatment of chronic idiopathic thrombocytopenic purpura (ITP) using vincristine Minerva Pediatrica 29(39): 2399-2405
Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221
Dostál, M. 1985: Teratogenic interactions of consecutively administered cortisone and cyclophosphamide Folia Morphologica 33(2): 201-208
Tabata, N.; Tanaka, R.; Suga, S.; Mitani, Y.; Nakano, T.; Ido, M.; Azuma, E.; Ito, M.; Hamazaki, M.; Shiraishi, T.; Sakurai, M. 1996: Rhabdomyolysis following administration of cyclophosphamide: a case report in a BMT recipient Bone Marrow Transplantation 17(6): 1167-1169
Pennington, J.E.; Matthews, W.J.; Marino, J.T.; Colten, H.R. 1979: Cyclophosphamide and cortisone acetate inhibit complement biosynthesis by guinea pig bronchoalveolar macrophages Journal of Immunology 123(3): 1318-1321
De Vita, S.; Fossaluzza, V. 1992: Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: clinical experience and a review of the literature Acta Neurologica Belgica 92(4): 215-227
Tirelli, U.; Carbone, A.; Veronesi, A.; Galligioni, E.; Trovò, M.G.; Tumolo, S.; Grigoletto, E. 1982: Combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP) in TNM-classified stage IV mycosis fungoides Cancer Treatment Reports 66(1): 167-169
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Abad-Esteve, A.; Rosell, R.; Moreno, I.; Fernández-Marcial, C.; Roselló, M.; Ribas Mundó, M. 1988: VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer Medicina Clinica 90(14): 569-572